Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Learn effective ways to make quick cash for emergency expenses. Be ready for financial surprises with these practical tips.
22,319 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Hewlett Packard Enterprise just blew past expectations with stronger revenue and profits, stoking the AI server rally...
CoreWeave’s latest trading session highlighted the tension between high-growth AI clouds and the realities of funding...
Micron stock sinking today signals short-term selling pressure in a volatile memory market. This article breaks down ...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
Super Micro Computer stunned investors with a colossal AI server backlog, but a planned $7 billion capital raise trig...
A patient fund manager shows strong conviction, piling another $10 million into Turning Point Brands. The move highli...
A long-running dividend payer with 70 straight years of increases is drawing buyers as its stock dips. The company pl...
A major investor liquidated a sizable stake as the decking stock down 35% over the past year. This article breaks dow...
Tilray Brands has evolved from a pure-play cannabis company into a diversified player. This guide breaks down what to...
Netflix has transformed how we watch TV, but investors are asking if the stock can reach $200. This article breaks do...
FactSet (FDS) investors are eyeing the Q3 2026 earnings with questions about growth, margins, and product strategy. T...